clairop

Peppermint Oil for IBS: What the Trials Show

Does peppermint oil work for IBS? Meta-analyzes say modestly, a 2020 trial missed its main goal, and heartburn is the common catch. Here is the evidence.

Clairop Team21 min read

Photo: Othman Alghanmi / Unsplash

The short answer

Peppermint oil beat placebo in two meta-analyzes of IBS trials, but the evidence is low quality, and the largest recent trial missed its primary pain endpoint. The American College of Gastroenterology makes a conditional suggestion for it. Heartburn is the usual side effect. Whether to try it is a decision for you and your doctor or pharmacist.

Trying to find your triggers? Clairop logs meals, symptoms and stool in seconds on iPhone, then flags foods your gut reacts to, including delayed reactions.

Get it on the App Store

If you have searched "peppermint oil for IBS", you have probably met two opposite claims: that it is a well-proven gut soother, and that it is a wellness myth. The honest answer sits between them. Peppermint oil has been tested in randomized trials, pooled analyzes mostly favor it over placebo, and a major guideline gives it a cautious thumbs up. But the evidence quality is low, one large and careful trial missed its main target, and heartburn is a real catch.

This guide goes deeper than our short summary in how to calm an IBS flare up. We describe what was tested, what the numbers were, and where the gaps are. We do not give doses, and we do not tell anyone to start or stop anything. Peppermint oil capsules are medicine-like products, and the decision belongs to you with your doctor or pharmacist, particularly if you take other medicines or have reflux.

Does peppermint oil work for IBS?

Probably modestly, but the evidence is low quality and not one-sided. Pooled analyzes of small trials favor peppermint oil over placebo, while the largest recent high-quality trial did not meet its primary endpoint. Both facts are true at once, and a fair summary has to hold them together.

The meta-analyzes

A 2019 meta-analysis pooled 12 randomized trials with 835 patients. For global symptom improvement, seven trials found a risk ratio of 2.39 in favor of peppermint oil over placebo, and the authors calculated a number needed to treat of three for global symptoms and four for abdominal pain. They concluded peppermint oil was a safe and effective therapy for pain and global symptoms in adults with IBS (Alammar 2019).

An earlier meta-analysis of enteric-coated peppermint oil capsules included nine studies and 726 patients. It reported superiority over placebo for global improvement (relative risk 2.23) and for abdominal pain (relative risk 2.14), and noted that adverse events were more common but mild and transient, with heartburn the most common (Khanna 2014). A still earlier analysis from 2008 found four trials in 392 patients with a relative risk of persistent symptoms of 0.43 against placebo (Ford 2008).

Why do the numbers look so different between reviews? They use different ways of expressing the effect. Some report the chance of improving, others the chance of not improving, and the studies included differ. The direction of the effect is the point: each favors peppermint oil.

The more cautious 2022 update

The most careful update came in 2022, after recent studies "cast doubt" on peppermint oil's role. It included 10 randomized trials with 1030 patients. Peppermint oil was still more efficacious than placebo for global IBS symptoms (relative risk of not improving 0.65, 95% CI 0.43 to 0.98, number needed to treat 4, with a very wide confidence interval of 2.5 to 71) and for abdominal pain (relative risk of not improving 0.76, 95% CI 0.62 to 0.93, number needed to treat 7). But adverse events were significantly more frequent with peppermint oil (relative risk 1.57), and the authors rated the quality of evidence as very low and called for adequately powered trials (Ingrosso 2022).

That confidence interval is worth a moment. A number needed to treat of 4 sounds impressive, but the range of 2.5 to 71 means the data are compatible with a strong effect and with a very weak one. This is what "very low quality" looks like in practice.

A 2026 meta-analysis of plant-based therapies for IBS pooled seven peppermint oil studies and found a risk ratio of 1.63 (95% CI 1.33 to 2.00) in favor of peppermint oil. The authors say the quality of many studies was limited and that further well-powered trials are needed (Meyer 2026).

The trial that missed its target

The PERSUADE trial (Weerts and colleagues, 2020) is the one that muddies the picture, and it deserves a fair description. It was a double-blind trial of 190 people with Rome IV IBS at four hospitals in the Netherlands, 189 in the intent-to-treat analysis. Participants were randomized to small-intestinal-release peppermint oil, ileocolonic-release peppermint oil, or placebo for 8 weeks (Weerts 2020).

The primary endpoint was the US Food and Drug Administration definition of abdominal pain response: at least a 30% decrease in weekly average worst daily abdominal pain for at least 4 weeks. The results:

GroupAbdominal pain respondersP value vs placebo
Small-intestinal-release peppermint oil29 of 62 (46.8%)0.170
Ileocolonic-release peppermint oil26 of 63 (41.3%)0.385
Placebo22 of 64 (34.4%)n/a

Neither peppermint group differed significantly from placebo. The co-primary endpoint, overall relief of IBS symptoms as defined by the European Medicines Agency, did not differ either.

However, the small-intestinal-release capsule did produce greater improvements than placebo in several secondary outcomes: abdominal pain (P = 0.016), discomfort (P = 0.020) and IBS severity (P = 0.020). Adverse events, although mild, were more common in both peppermint groups. The authors concluded the findings did not support further development of the ileocolonic-release formulation (Weerts 2020).

How should you read this? A primary endpoint is the question the trial was designed to answer, so missing it matters. Secondary outcomes that reach significance are more fragile, because testing many outcomes raises the chance that one looks good by luck. It would be a mistake to say the trial "proved" peppermint oil works, and equally a mistake to say it "proved" it does not. It shows that when a strict, regulator-style definition of response is used, the benefit over a substantial placebo response was not clearly demonstrated. Notice also that the placebo group had a 34.4% pain response. IBS trials routinely show large placebo responses, which makes small true effects hard to detect.

A separate analysis of the same trial looked at cost. In 126 patients with complete data, small-intestinal-release peppermint oil was judged likely to be cost-effective, with a 56% probability at a conservative threshold per quality-adjusted life year and 89% when measured per abdominal pain responder, although the authors flag uncertainty (Weerts 2021). That is an economic estimate built on the same trial, not independent proof of benefit.

A short-term, single-formulation trial with fast results

A 4-week trial in 72 people with IBS-M or IBS-D tested a sustained-release small-intestine formulation three times daily. The total IBS symptom score fell 40% with peppermint oil versus 24.3% with placebo (P = 0.0246), and a difference was already reported at 24 hours (Cash 2016). It is one small trial of one product, so it cannot be generalized, but it is part of why people ask whether peppermint oil works quickly.

What the evidence can and cannot tell you

  • It can say: in group averages, many trials found more people improved on peppermint oil than on placebo.
  • It cannot say: that it will work for you, how large your benefit will be, or that a given shop-bought product matches what was tested.
  • It cannot say: that it is better than other options. Comparisons with antispasmodics, antidepressants, fiber or diet changes are thin.

Doctors and pharmacists weigh the same uncertainty, which is why the conversation is worth having instead of choosing from a shelf.

How is peppermint oil thought to work?

Several mechanisms have been proposed, and none is proven to explain the benefit in IBS. The best-known idea is that menthol relaxes gut muscle. The others involve pain signaling and, more speculatively, gut microbes and inflammation.

A review of the physiology and safety literature lists the proposed mechanisms as smooth muscle relaxation (through calcium channel blockade or direct effects on the enteric nervous system), modulation of visceral sensitivity through transient receptor potential cation channels, antimicrobial effects, anti-inflammatory activity and modulation of psychosocial distress. It also reports that peppermint oil affects esophageal, gastric, small bowel, gallbladder and colonic physiology (Chumpitazi 2018). The American College of Gastroenterology guideline says the clinical benefits have most often been attributed to menthol's blockade of calcium channels and the resulting smooth muscle relaxation, and lists the other explanations as worthy of consideration (Lacy 2021).

In plain English, the two most discussed ideas are:

  1. Relaxing muscle. Gut muscle contracts in waves. If those contractions are strong or poorly coordinated, they may contribute to cramping. A substance that relaxes smooth muscle might ease that.
  2. Dialling down pain signals. In IBS the gut can be unusually sensitive, so ordinary movement or stretch is felt as pain. Peppermint's effects on certain sensory channels might change how those signals are perceived.

These are mechanisms studied in laboratory and physiology experiments. A mechanism being plausible does not mean it is what produces symptom relief in a person with IBS, and the trials are the evidence that matters for that.

Why formulation matters

Peppermint oil taken as a plain liquid or standard capsule can release in the stomach and esophagus. Trial products were typically designed to survive the stomach and release further down. In PERSUADE, one capsule released in the small intestine and another in the ileum and colon (Weerts 2020). Release site affected results: the small-intestinal formulation outperformed placebo on several secondary outcomes, while the ileocolonic formulation did not. A Reddit thread comparing capsules makes the same point informally, which we come back to below.

This is also why general health-food peppermint products may not behave like the products in trials. The American College of Gastroenterology notes that only a small number of commercially available peppermint oil supplements have undergone rigorous efficacy and safety testing (Lacy 2021).

Is peppermint tea as good as peppermint oil capsules for IBS?

We found no randomized trial of peppermint tea for IBS. The trials above all tested peppermint oil, in capsule form with delayed or targeted release. A cup of tea is a very different exposure, so the capsule results should not be assumed to apply to it.

There are several practical differences:

  • Amount and form. Tea is a dilute infusion. Capsule products in trials were concentrated oil in a delivery system. We are not describing doses, only noting that they are not comparable.
  • Where it acts. The point of the trial formulations was to release in the intestine. Tea is swallowed as a drink and is exposed to the stomach and esophagus first.
  • Reflux. Because peppermint oil can affect the lower esophageal sphincter, people prone to reflux may notice peppermint products, including tea, differently. We found no trial testing peppermint tea for reflux in IBS, so this is a reasonable caution rather than a measured finding.

NICE advises that people with IBS drink plenty of fluids and names herbal teas among non-caffeinated options, but that is advice about hydration, not a finding that peppermint tea treats IBS. A warm drink may be pleasant and may help you slow down and relax, which is a reasonable thing to like about it. We just have no trial evidence that it does more.

If you are curious whether tea or anything else affects you (our guide to how to keep a food diary for IBS covers the method), a log is a gentler experiment than a conclusion. Our guide to the IBS and GERD food and symptom diary shows how to track reflux alongside gut symptoms, which is relevant here because heartburn is the side effect that stops many people using peppermint products.

What do guidelines say about peppermint oil for IBS?

The American College of Gastroenterology gives it a cautious yes. NICE does not mention it by name. Guidelines also differ in how they treat natural products and which evidence they weigh.

ACG 2021

The ACG guideline states: "We suggest the use of peppermint to provide relief of global IBS symptoms," graded as a conditional recommendation with low quality of evidence. Its summary was that peppermint oil may offer benefit for overall symptoms and abdominal pain, and has mostly been well tolerated in the available trials. The guideline also points out limits. The included studies were small (18 to 178 people with IBS) and short (2 to 12 weeks). They did not allow a meaningful analysis by IBS subtype. All evaluated continuous dosing, and none tested as-needed use. It described the PERSUADE results, and it noted that peppermint oil's effects on the esophagus and lower esophageal sphincter can lead to heartburn in some people, with enteric-coated formulations possibly offering benefits in this regard (Lacy 2021).

"Conditional" and "low quality" are the guideline's own words. A conditional recommendation means the balance of benefit and harm is closer and individual preferences and circumstances matter, which fits a decision made with your clinician.

NICE

The NICE IBS guideline (CG61) says healthcare professionals should consider prescribing antispasmodic agents for people with IBS, taken as required alongside dietary and lifestyle advice. In the recommendation text we reviewed, peppermint oil is not named, and the complementary and alternative medicine section covers acupuncture and reflexology, which it says should not be encouraged (NICE CG61). So "NICE recommends peppermint oil" would be inaccurate. What NICE endorses is the class of antispasmodics. Peppermint oil is itself sometimes grouped with antispasmodics in clinical conversations because of its muscle-relaxing action, which is why the Ford meta-analysis evaluated it alongside them (Ford 2008), but that is a categorization by researchers, not a NICE recommendation.

BSG 2021

The British Society of Gastroenterology also published an IBS management guideline in 2021 (Vasant 2021). We could not open its full text in preparing this article, so we are not characterizing what it says about peppermint oil. If you want to know how UK guidance treats it, ask your doctor or pharmacist, or read the guideline directly.

Clairop logs meals, symptoms and stool in seconds, then looks for the foods your gut reacts to, including reactions that land days later.

Download on the App Store

What are the side effects of peppermint oil, and who should be careful?

Heartburn is the side effect to know about, and several groups should check with a pharmacist or doctor before using peppermint oil products. Most adverse events in trials were mild, but that does not mean there is no risk for you. Peppermint oil capsules have been tested in IBS trials, which is not true of every essential oil promoted for gut symptoms; for another popular one, see does oregano oil cure SIBO.

What the trials report

  • A meta-analysis of enteric-coated capsules found people on peppermint oil were more likely to have an adverse event than people on placebo. They were described as mild and transient, and heartburn was the most common (Khanna 2014).
  • The 2022 update found adverse events significantly more frequent with peppermint oil (relative risk 1.57) (Ingrosso 2022).
  • Interestingly, the earlier 2019 analysis, as summarized in the ACG guideline, found adverse event rates of 9.3% with peppermint oil and 6.1% with placebo in eight trials, which was not statistically significant (Lacy 2021). Different reviews, different trial mixes, slightly different answers. The safe reading is that side effects are somewhat more common than with placebo.
  • PERSUADE also reported adverse events as mild but more common in both peppermint groups (Weerts 2020).
  • In a Japanese open-label study of 69 people, adverse events occurred in 14 (20.3%), none serious (Matsueda 2024).

Who should be careful

Based on what the sources above say, these are the situations where a conversation with a doctor or pharmacist first makes particular sense:

  • If you already have heartburn or reflux. Peppermint oil affects the lower esophageal sphincter, according to the guideline's reading of the evidence, and heartburn is the leading reported adverse event.
  • If you take other medicines or supplements. We did not review drug interaction data for this article, so we cannot tell you whether a given combination is a problem. A pharmacist can check.
  • If you are pregnant, breastfeeding, or giving anything to a child. Our sources studied adults. We are not making a safety claim for these groups.
  • If your symptoms are new, changing or include red flags. Peppermint oil is for symptom relief in diagnosed IBS, not for working out what is going on.

Long-term safety is also unproven. The pooled trials lasted 2 to 12 weeks, and the 2014 authors called for studies of long-term efficacy and safety (Khanna 2014).

When to see a doctor promptly

Blood in the stool, unexplained weight loss, fever, symptoms that wake you at night, anemia, symptoms starting after age 50, or a family history of bowel cancer or inflammatory bowel disease should be checked by a doctor promptly. Do not treat these with peppermint or any other self-chosen product. If you have started something and you are getting worse, or chest pain that could be heartburn but could be something else, seek medical help promptly.

What people in the community describe

Peppermint capsules generate strong opinions. In a r/ibs thread about peppermint-oil capsules, people described very different experiences (r/ibs thread). Some said it caused painful indigestion or acid reflux, and a few said it did not help at all. Others said they liked it. Several discussed that products differ, including where in the gut they release, and a few noticed minty burps or a cooling sensation when passing stool. One person said a rebound in loose stools several hours later became clear only after they logged what they were eating through the day.

These are personal accounts, not evidence. They do reinforce two points from the research: formulation and release site matter, and side effects are real for a subset of people. They also show why a log is useful, which we turn to next.

Does peppermint oil help IBS-C, IBS-D or IBS-M?

The evidence does not say. No subtype has strong proof either way. If a product page claims it works for a particular subtype, the trials do not currently back that up.

The ACG guideline states directly that the studies in the main meta-analysis "did not allow for a meaningful analysis by the IBS subgroup (e.g., IBS-D, IBS-C, and IBS-M)" (Lacy 2021). That is the key fact. What we have by subtype is fragmentary:

  • IBS-D and IBS-M. One 4-week trial enrolled only people with IBS-M or IBS-D and reported benefit over placebo with a sustained-release formulation (Cash 2016). It was a single trial of 72 people.
  • All types. An open-label, single-arm study in Japan reported improvement across IBS-C, IBS-D and mixed or unsubtyped IBS. With no placebo group, however, an open-label study cannot separate drug effect from placebo response, which is large in IBS (Matsueda 2024).
  • IBS-C. We did not find a controlled trial of peppermint oil specifically in IBS-C. People in r/ibs sometimes ask about it, but a forum question is not evidence.

This matters for a practical reason. Peppermint oil relaxes smooth muscle. For some people with diarrhea-predominant symptoms that may sound helpful, and for people with constipation it could in theory go the other way, but we did not find trial data on either effect, so we are not going to guess. What your own stool pattern does is better judged from a record than from theory. A Bristol-scale log over several weeks makes it clear whether anything changed in consistency or frequency. We explain the types in our guide to IBS types.

How would you tell whether it is helping you?

A symptom log is the fairest test you have, as long as you are honest about what it can show. A log cannot prove cause, but it can stop a good week or a bad week from being mistaken for a trend.

IBS symptoms fluctuate and placebo responses are high, so impressions are unreliable. If you and your doctor decide to try something, a simple approach is:

  1. Record a baseline first. A week or two of pain, bloating, stool type and urgency before any change.
  2. Change one thing at a time. If you alter your diet, caffeine and a supplement in the same two weeks, you will not know which mattered.
  3. Record side effects as they appear. Reflux, burping, a change in stool, and the time relative to taking anything.
  4. Review after a few weeks, not days. Trials lasted 2 to 12 weeks.
  5. Bring the log to your appointment.

Clairop is an iPhone app where you can log meals, one-tap Bristol stool entries with blood, mucus, urgency and night-time detail, symptoms and medication in one place. It is free to download and set up, and using it requires a Clairop Pro subscription. It is not a medical device, is not clinically validated and does not diagnose, so it cannot tell you whether peppermint oil works for you. Its role is only to keep the record tidy. See how Clairop works for what it does and does not do.

If you are also considering other non-drug options, the evidence for gut-directed hypnotherapy is a useful comparison, since it was studied over weeks as well. We cover it in does gut-directed hypnotherapy work for IBS.

Common myths and questions

"Natural means safe." Natural products can have adverse effects and interactions. The trial data show more adverse events with peppermint oil than placebo, with heartburn leading the list.

"It is a proven treatment." Not by the standards of the most recent analysis, which called the evidence very low quality (Ingrosso 2022). "Has trial support and a conditional guideline suggestion" is accurate. "Proven" is not.

"It does not work at all because PERSUADE failed." Also too strong. PERSUADE missed its primary endpoint but showed improvements in secondary outcomes with one formulation, and pooled analyzes favor peppermint oil. The honest position is uncertainty about size and consistency of benefit.

"Any peppermint product will do." The trials tested specific formulations. Standard shop products may not match them, and the guideline says few commercial products have been rigorously tested (Lacy 2021).

"It will switch off a flare." Trials ran for weeks. One small trial reported a difference from placebo at 24 hours (Cash 2016), but nobody has shown a reliable minutes-scale effect.

The practical takeaways

Peppermint oil sits in a middle zone. It has more randomized-trial support than many supplements marketed for IBS, a conditional suggestion from the American College of Gastroenterology, and a plausible mechanism. It also has low-quality evidence, a high-profile trial that missed its primary goal, a clear side-effect signal and no good evidence on tea or specific subtypes.

If you are weighing it up, the useful questions for a doctor or pharmacist are:

  • Is it suitable for me given my reflux, other medicines and other conditions?
  • Which formulation, if any, matches what was studied?
  • How long should we give it before deciding, and what would count as not working?
  • What else, including diet, gut-directed therapy or prescription antispasmodics, should be on the table?

You can take the log from the previous section to that appointment. If you use Clairop, its one-page GI visit report summarizes what you recorded and is labeled as patient-entered data, so a clinician knows it is your account and not a measurement. You can export or delete your data with or without a subscription.

Finally, if your IBS symptoms are changing, getting worse, or include any of the red flags above, that is a reason to see a doctor promptly, not a reason to try a different product.

Frequently asked questions

Does peppermint oil work for IBS?
Modestly, on low-quality evidence. A 2022 meta-analysis of 10 trials (1030 patients) found peppermint oil beat placebo for global symptoms and abdominal pain, with more adverse events. The 2020 PERSUADE trial of 190 people missed its primary pain endpoint but improved some secondary outcomes. Talk to a doctor or pharmacist before trying it.
What's the best peppermint oil for IBS?
No product has been shown to be best. Trials tested specific formulations, mostly enteric-coated or small-intestinal-release capsules, and the American College of Gastroenterology notes only a small number of commercial products have been rigorously tested. Ask a doctor or pharmacist which formulation, if any, suits you, especially if you have reflux or take other medicines.
Is peppermint tea as good as peppermint oil for IBS?
Unknown. We found no randomized trial of peppermint tea for IBS. The trials used peppermint oil capsules designed to release in the intestine, so their results should not be assumed to apply to a cup of tea. NICE lists herbal teas among non-caffeinated drinks, and tea may be pleasant, but that is not evidence of benefit.
What are the side effects of peppermint oil for IBS?
Heartburn was the most commonly reported adverse event in a 2014 meta-analysis, and a 2022 meta-analysis found adverse events more frequent than with placebo, though the trials reported them as mild. The American College of Gastroenterology links peppermint oil's effect on the lower esophageal sphincter to heartburn. Ask a pharmacist if you have reflux or take other medicines.
Does peppermint oil help IBS-C or IBS-D?
The evidence does not say. The American College of Gastroenterology reports that the pooled trials did not allow a meaningful analysis by IBS subtype. One 72-person trial enrolled only IBS-D and IBS-M, and a Japanese open-label study reported benefit in all types, but it had no placebo group. Subtype-specific proof is missing.
What do IBS guidelines say about peppermint oil?
The American College of Gastroenterology suggests peppermint to relieve global IBS symptoms, a conditional recommendation on low-quality evidence. The NICE IBS guideline recommends considering antispasmodics taken as required but does not name peppermint oil in its recommendations. Neither is a substitute for a clinician's advice about you.
How long does peppermint oil take to work for IBS?
Trials measured results over 2 to 12 weeks, not minutes. One 4-week trial of a sustained-release formulation reported a symptom-score difference from placebo at 24 hours, but that is a single small study. Do not expect an instant switch-off, and tell a clinician if symptoms persist or worsen.
Can peppermint oil make IBS or reflux worse?
It can cause heartburn in some people, because peppermint oil affects esophageal and lower esophageal sphincter function according to the American College of Gastroenterology. People in r/ibs also describe reflux or a rebound loosening of stools after capsules. Anyone with reflux should check with a pharmacist or doctor first.
Is peppermint oil for IBS safe long term?
Long-term safety is not established. The pooled trials were short, 2 to 12 weeks, and a 2014 meta-analysis called for long-term studies. Most reported adverse events were mild and transient. Because it is medicine-like, ask a doctor or pharmacist about long-term use, especially alongside other medicines.
What's the best way to know if peppermint oil is helping my IBS?
Keep a symptom log for a few weeks before and during any change, so you can compare pain, bloating and stool pattern. Clairop logs Bristol stool entries, symptoms and medication in one place, and its report is patient-entered data you can bring to a doctor. A log shows association, not proof.

Sources

  1. Alammar N, Wang L, Saberi B, Nanavati J, Holtmann G, Shinohara RT, et al. The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data. BMC Complement Altern Med. 2019;19(1):21. doi:10.1186/s12906-018-2409-0
  2. Ingrosso MR, Ianiro G, Nee J, Lembo AJ, Moayyedi P, Black CJ, et al. Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome. Aliment Pharmacol Ther. 2022;56(6):932-941. doi:10.1111/apt.17179
  3. Weerts ZZRM, Masclee AAM, Witteman BJM, Clemens CHM, Winkens B, Brouwers JRBJ, et al. Efficacy and safety of peppermint oil in a randomized, double-blind trial of patients with irritable bowel syndrome. Gastroenterology. 2020;158(1):123-136. doi:10.1053/j.gastro.2019.08.026
  4. Khanna R, MacDonald JK, Levesque BG. Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. J Clin Gastroenterol. 2014;48(6):505-512. doi:10.1097/mcg.0b013e3182a88357
  5. Ford AC, Talley NJ, Spiegel BM, Foxx-Orenstein AE, Schiller L, Quigley EMM, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ. 2008;337:a2313. doi:10.1136/bmj.a2313
  6. Cash BD, Epstein MS, Shah SM. A novel delivery system of peppermint oil is an effective therapy for irritable bowel syndrome symptoms. Dig Dis Sci. 2016;61(2):560-571. doi:10.1007/s10620-015-3858-7
  7. Chumpitazi BP, Kearns GL, Shulman RJ. Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders. Aliment Pharmacol Ther. 2018;47(6):738-752. doi:10.1111/apt.14519
  8. Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, et al. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol. 2021;116(1):17-44. doi:10.14309/ajg.0000000000001036
  9. Meyer A, Auer J, Cascant-Ortolano L, Schreiber N, Zimmermann M, et al. Systematic review and meta-analysis: plant-based therapy for irritable bowel syndrome. Phytother Res. 2026:5918-5950. doi:10.1002/ptr.70421
  10. Matsueda K, Fukudo S, Ogishima M, Naito Y, Nakamura S. Efficacy and safety of peppermint oil for the treatment in Japanese patients with irritable bowel syndrome: a prospective, open-label, and single-arm study. Biopsychosoc Med. 2024;18:3. doi:10.1186/s13030-024-00302-y
  11. Weerts ZZRM, Essers BAB, Jonkers DMAE, Willems JIA, Janssen DE, et al. A trial-based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome. United European Gastroenterol J. 2021;9(9):997-1006. doi:10.1002/ueg2.12134
  12. Vasant DH, Paine PA, Black CJ, Houghton LA, Everitt HA, Corsetti M, et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut. 2021;70(7):1214-1240. doi:10.1136/gutjnl-2021-324598
  13. National Institute for Health and Care Excellence. Irritable bowel syndrome in adults: diagnosis and management (CG61). Recommendations 1.2.2 and 1.2.4. https://www.nice.org.uk/guidance/cg61/chapter/1-Recommendations

Clairop is a general wellness app for people living with a diagnosed digestive condition. It does not replace professional medical care, diagnosis, or treatment. Always follow your healthcare provider's advice.

Clairop logs meals, symptoms and stool in seconds, then looks for the foods your gut reacts to, including reactions that land days later.

Download on the App Store

Free tools